Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02353806 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02353806 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants.
The verdict
NCT02353806, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a phase IV prospective trial to collect and analyze information about the maternal pharmacokinetics of amlodipine besylate at the time of delivery and during postpartum lactation. The study will also evaluate amlodipine concentrations in the infants of breastfeeding mothers who are taking amlodipine besylate for treatment chronic hypertension.
Interventions
- DRUG Amlodipine besylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02353806
The ClinicalTrials.gov registry entry for NCT02353806 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amlodipine besylate is the first listed.
NCT02353806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02353806 about?
NCT02353806 is a clinical study titled "Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation". This is a phase IV prospective trial to collect and analyze information about the maternal pharmacokinetics of amlodipine besylate at the time of delivery and during postpartum lactation. The study will also evaluate amlodipine concentrations in the infants of breastfeeding mothers who are taking am...
What is the current status of trial NCT02353806?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2015-01. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02353806?
The interventions under investigation include: Amlodipine besylate (DRUG).
Who is sponsoring clinical trial NCT02353806?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.